Home Search
tax exclusion health insurance - search results
If you're not happy with the results, please do another search
Tax Exclusion for Employer-Sponsored Health Insurance in the Spotlight
“If we got rid of the exclusion, what would happen to the $1.3 trillion (currently) denied workers? They would make their own health care decisions. They would have more control over their incomes, transferring control from employers to employees and allowing them to purchase health insurance tax-free. They could still stay in employer-provided plans if they choose to do so.”
Government Subsidies Make Health Care More Expensive – Commentary
"A guiding principle for reforming government health financing would be to allow Americans to control more of their own money for health care and coverage rather than to continue to have the government control how most of their money is spent."
All Workers Should Get the Same Tax Break on Health Care Costs – Interview
An HFA makes the tax savings, on a comparable amount of earned income, available to all workers to apply toward their health care needs. Equality of opportunity.
The Republican Study Committee Budget on the Key Drivers of Spending and Debt
The House and Senate both have budget committees. And yet, neither chamber has released a budget this year. Against this backdrop, it’s refreshing to see...
Life, Liberty, Property #15: Out-Foxed
Out-Foxed Tucker Carlson may do well as viewers cut the cord of cable-TV in favor of streaming.
SUBSCRIBE to Life, Liberty & Property (it's free)....
Veronique de Rugy: Congress Has a Fiscal Road Map — It Just Needs to...
Maintaining federal spending at its current level is not a viable option, columnist Veronique de Rugy says
Dealing with high inflation and an increasingly...
Clarity in Trump’s Wake: An Essay
The United States of America is now a classic oligarchy. The clarity that it has brought to our situation by recognizing this fact is...
Drug Companies Stall on Generic Drug Releases
The U.S. Food & Drug Administration has approved generic versions of pharmaceutical products at a record-setting pace since 2016, but few of the newly certified products are available to patients, according to an analysis by Iqvia.